Triple
T13942308
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer–BioNTech |
E335285
|
entity |
| Predicate | hasVariantSpecificFormulations |
P92195
|
FINISHED |
| Object | Omicron‑adapted COVID‑19 vaccine |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Omicron‑adapted COVID‑19 vaccine | Statement: [Pfizer–BioNTech, hasVariantSpecificFormulations, Omicron‑adapted COVID‑19 vaccine]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasVariantSpecificFormulations Context triple: [Pfizer–BioNTech, hasVariantSpecificFormulations, Omicron‑adapted COVID‑19 vaccine]
-
A.
isExtendedReleaseFormulationOf
Indicates that one pharmaceutical formulation is an extended-release version of another, designed to release the active ingredient more slowly over time.
-
B.
hasDosageForm
Indicates the specific physical form or presentation in which a drug or medicinal product is supplied or administered (e.g., tablet, injection, cream).
-
C.
hasNicotineVariants
Indicates that one entity offers or includes different forms, strengths, or types of nicotine associated with another entity.
-
D.
hasCommercialVariant
chosen
Indicates that an entity has a related version that is produced, marketed, or sold commercially.
-
E.
coFormulated
Indicates that two or more entities were jointly formulated, designed, or created together as part of the same process or product.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6081b88190b53e317c3370c8fe |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e0f6f3c8190a64058b732b0ac52 |
completed | April 14, 2026, 12:07 p.m. |
| PD | Predicate disambiguation | batch_69de05a3ccf88190b45c742db483fa08 |
completed | April 14, 2026, 9:15 a.m. |
Created at: April 9, 2026, 10:17 p.m.